PLBY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
PLBY is not a good buy right now. Despite being deeply oversold, the trend signals are still bearish (negative and expanding MACD), there are no Intellectia buy signals, and the latest quarter shows weakening earnings power. For an impatient buyer who doesn’t want to wait for confirmation, the current setup skews toward further downside rather than a high-confidence bounce.
Trend/momentum remains bearish. The MACD histogram (-0.0367) is below zero and negatively expanding, which typically signals downside momentum is strengthening rather than stabilizing. RSI(6) at 15.23 is extremely oversold, which can produce sharp dead-cat bounces, but without reversal confirmation it’s not a reliable entry. Price is trading below S1 (1.594) with the next support at S2 (1.476); resistance overhead is the pivot (1.785) then R1 (1.976). Converging moving averages suggest compression, but with MACD weakening, the bias remains down until price reclaims at least the pivot area. Pattern-based forward stats also lean slightly negative over 1D/1W/1M.
Technical mean-reversion potential: RSI(
~15 is deeply oversold and can spark a short-term bounce if buyers step in.
Gross margin improved sharply to ~76.02% in 2025/Q3 (+24.58% YoY), which could become a narrative catalyst if sustained.
Extremely call-skewed options positioning can sometimes fuel short-term upside bursts if price starts to lift through near resistance.
Momentum is still deteriorating (MACD negative and expanding), implying selling pressure hasn’t exhausted.
Price is below near-term support (S1 1.594), with room to drift toward S2 1.
Latest quarter shows weakening profitability (net income and EPS down sharply YoY), limiting fundamental support.
No recent news catalysts in the past week to justify an immediate reversal or re-rating.
Hedge funds and insiders show neutral activity, offering no strong confidence signal.
2025/Q3: Revenue was $28.994M, down -1.51% YoY (slight contraction). Net income was $0.46M, down -101.36% YoY, and EPS fell to 0 (-100% YoY), indicating a major deterioration in earnings power versus last year. The notable bright spot is gross margin at 76.02% (+24.58% YoY), but margin expansion didn’t translate into earnings growth in the quarter, which is a negative near-term signal for buyers.
No analyst rating/price target change data was provided, so there’s no visible recent Street upgrade/downgrade trend to lean on. With the available information, the Wall Street pro case would be margin improvement and optionality from a turnaround; the con case is deteriorating bottom-line performance, weak momentum, and lack of a clear catalyst.
